Home » Newsletters » BioWorld Asia

BioWorld Asia

April 26, 2000

View Archived Issues

CeNeS, Bioglan Expand Alliance On Pain Control, Drug Delivery

Stimulating Environment Delays Onset Of Huntington's In Mice

Artemis Launching International Project On Screening Zebrafish

Devgen Getting $15M Through Expansion Of Deal With FMC

Astex Formed To Improve Upon Speed Of X-Ray Crystallography

Biovector Moves Lipomel Into Phase II Studies For Cancers

Prana Using IPO Proceeds To Further Develop CNS Therapies

Girindus Plans To Go Public On German Market Next Month

GeneFocus, Collaborators Plan New Biochip Facility In Ottawa

Flamel Validates Medusa System In Study Involving Insulin Delivery

French Officials Release Details Of GM Oil Seed Rape Trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...